170 related articles for article (PubMed ID: 37108958)
1. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
Ding Y; Su N; Luan J; Ni Y; Sun Z
J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
[TBL] [Abstract][Full Text] [Related]
2. Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.
Wang Q; Cai H; Xu D; Cui L; Zhang Y; Chen M
Am J Transl Res; 2022; 14(2):1324-1331. PubMed ID: 35273734
[TBL] [Abstract][Full Text] [Related]
3. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
7. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy.
Wang W; Qu C; Yan H
Front Endocrinol (Lausanne); 2023; 14():1098165. PubMed ID: 36896181
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.
Yang X; Xu J; Wang R; Mei Y; Lei H; Liu J; Zhang T; Zhao H
J Ophthalmol; 2016; 2016():2473234. PubMed ID: 27034822
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy.
Yang Z; Di Y; Ye J; Yu W; Guo Z
Front Endocrinol (Lausanne); 2023; 14():1171628. PubMed ID: 37305048
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.
Cui J; Chen H; Lu H; Dong F; Wei D; Jiao Y; Charles S; Gu W; Wang L
J Ophthalmol; 2018; 2018():4927259. PubMed ID: 30046459
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.
Demir M; Oba E; Can E; Kara O; Cinar S
Ophthalmol Eye Dis; 2013; 5():11-5. PubMed ID: 23926440
[TBL] [Abstract][Full Text] [Related]
15. Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients.
Li S; Tang J; Han X; Wang Z; Zhang L; Zhao M; Qu J
Ophthalmol Ther; 2022 Oct; 11(5):1833-1845. PubMed ID: 35904708
[TBL] [Abstract][Full Text] [Related]
16. Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.
Zhang Y; Gao Z; Zhang X; Yuan Z; Ma T; Li G; Gao X
Exp Ther Med; 2021 Apr; 21(4):332. PubMed ID: 33732305
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.
Patel V; Rohowetz LJ; Pakravan P; Kalavar M; Yannuzzi NA; Sridhar J
Clin Ophthalmol; 2023; 17():471-478. PubMed ID: 36755887
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
Hu L; Chen Q; Du Z; Wang W; Zhao G
Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
[TBL] [Abstract][Full Text] [Related]
20. 27‑Gauge vitrectomy vs. 25‑gauge vitrectomy in the management of proliferative diabetic retinopathy with preoperative intravitreal injection of conbercept.
Xiang W; Fang D; Jiang X; Zhang Z; Xiang C; Huang S; Zhang S; Wei Y
Exp Ther Med; 2023 Oct; 26(4):472. PubMed ID: 37664677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
